Selahattin Öztaş

Selahattin Öztaş

Auto-generated profile, based on publicly available information

Selahattin Öztaş

Clinic of Chest Diseases, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2025 in Kastamonu Medical Journal
Verified
Journal Article
Open access
PDF file
GDGül Erdal Dönmez
Gül Erdal Dönmez
SÖSelahattin Öztaş
Selahattin Öztaş
DEDilek Ernam
Dilek Ernam
Aims: Transthoracic needle aspiration biopsy (TTNAB) is used to diagnose thoracic lesions and has a wide range of indications and few contraindications. The aims of this study were to assess the diagnostic value and complication rate of computed tomography-guided TTNAB for malignant diseases, to identify factors that influence diagnostic value and complication rate, and to compare our practices to those described in the literature. Methods: A retrospective, observational, and cross-sectional study was designed to investigate the complication incidence and diagnostic value of the TTNAB. In Our study, 208 patients who underwent computed tomography-guided transthoracic needle aspiration biopsy at our hospital by pulmonologists between July 2007 and February 2013 were analyzed. In addition to descriptive statistical methods the Pearson Chi-Square test was used to compare quantitative data when evaluating the study's data. The significance level of the results was accepted as p<0.05 with a 95% confidence interval. Results: The ages of the patients ranged from 33 to 88 years and the 179 of them were male. The procedure's outcomes and rates of complications were documented. To evaluate the diagnostic value, we analyzed the clinical and radiologic follow-up results of 136 patients whose data were available. The rate of malignant diagnoses was 72.1%, while the rate of benign diagnoses was 4.4%. For malignant lung tumors, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of the procedure were calculated to be 80%, 93%, 99%, 37%, and 82%, respectively. The only observed complication was pneumothorax, which occurred in 8 of 208 patients (3.8%). Diagnostic value and complication rate were unaffected by lesion size and needle thickness. Conclusion: According to the findings of this study, computed tomography-guided TTNAB procedures in the diagnosis of malignant thoracic lesions have good diagnostic accuracy and low complication rates, which is consistent with litreture.

1 January 2020 in Tuberk Toraks
Verified
Journal Article
Closed access
SKSoner Umut Küver
Soner Umut Küver
FAFatma Tokgöz Akyil
Fatma Tokgöz Akyil
SÖSelahattin Öztaş
Selahattin Öztaş
BGBaran Gündoğuş
Baran Gündoğuş
NÇNurcan Çeti̇n
Nurcan Çeti̇n
TSTülin Sevi̇m
Tülin Sevi̇m
Introduction: The aim of the present study is to investigate the diagnostic value of the CD4+, CD8+ and CD103+ lymphocyte sub-groups in mediastinal lymph nodes, as an adjunctive marker in sarcoidosis. Materials and Methods: The present study is a single-center, prospective cohort study designed in a reference center for chest diseases. Forty-six patients who underwent endobronchial ultrasound (EBUS)-guided mediastinal lymph node sampling with a preliminary diagnosis of sarcoidosis were enrolled. the different lymphocyte subgroups were counted by flow cytomeytry in lymph node biopsy samples. Based on the final diagnosis, subjects were divided into two groups: sarcoidosis and non-sarcoidosis. Lymphocyte subset analysis were compared between the groups. Results: The final diagnoses were sarcoidosis in 31 (67%) and non-sarcoidosis in 15 patients (33%). The total cell counts, lymphocyte ratios, CD8+ T lymphocyte ratios and CD4/CD8 ratios were similar in both groups (p> 0.05). CD4+ T lymphocyte rates were higher in patients with sarcoidosis (p= 0.017). CD103 subset analysis revealed significantly lower CD103+CD4+, CD103+CD8+ lymphocytes and CD103+CD4+/CD4+ ratios in sarcoidosis (p= 0.008, p= 0.048, p= 0.014, respectively). Conclusion: Cytological examination of EBUS-guided lymph node samples may provide substantial findings in differential diagnosis of sarcoidosis. Patients with sarcoidosis have higher CD4+ lymphocytes, lower CD103+CD4+ lymphocytes and CD103+CD4+/CD4+ and CD103+CD8+ lymphocyte ratios. These subsets of lymphocytes in lymph node biopsies may be novel predictors of sarcoidosis diagnosis.

22 September 2025 in Tuberk Toraks
Verified
Journal Article
Closed access
BGBaran Gündoğuş
Baran Gündoğuş
TYTekin Yıldız
Tekin Yıldız
MAMeltem Ağca
Meltem Ağca
SÖSelahattin Öztaş
Selahattin Öztaş
ÜAÜlkü Aka Aktürk
Ülkü Aka Aktürk
BOBirsen Ocaklı
Birsen Ocaklı
Sarcoidosis is a chronic and inflammatory multisystemic disease of unknown origin that causes various clinical manifestations. Epidemiologic data vary by numerous variables such as age, geographical location, sex, race, as well as genetic and environmental factors. Epidemiologic data help better characterize the heterogeneous disease of sarcoidosis, as in many other diseases, and facilitate a prognostic assessment. Thus, the present study sought to analyze epidemiologic data and changes in diagnostic strategies used in sarcoidosis over time. The study reviewed patients who were diagnosed with sarcoidosis between January 01, 2011 and December 31, 2020, and had non-necrotizing granulomatous inflammation in at least one thoracic biopsy material. Data from a total of 1.200 patients, of whom 768 (64%) were females and 432 were males (female/male: 1.77), were reviewed over a 10-year period. The results showed an increasing trend in the frequency of sarcoidosis in the 10-year period and an increasing incidence for males after 2015. The rate of asymptomatic patients was 15%, and asymptomatic sarcoidosis was significantly higher in males than in females. After 2012, video-assisted mediastinoscopy was replaced with endobronchial ultrasoundguided transbronchial needle aspiration as the preferred diagnostic technique. Epidemiologic data associated with sarcoidosis are likely to continue changing because of multiple factors such as health policies and technological changes and development. We believe that it is necessary to constantly monitor epidemiological changes in different geographical regions in the world.